Eligibility Skin Neoplasms NCT01482104

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male/female above 18 years of age
Description

gender; age

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
written informed consent
Description

informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
1 or more primary histologically verified bcc, clinically assessed as of either superficial of nodular type
Description

Basal Cell Carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0007117
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnancy
Description

pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0032961
breastfeeding
Description

breastfeeding

Data type

boolean

Alias
UMLS CUI [1]
C0006147
gorlin's syndrome
Description

gorlins syndrome

Data type

boolean

Alias
UMLS CUI [1]
C0004779
porphyria
Description

porphyria

Data type

boolean

Alias
UMLS CUI [1]
C3463940
xeroderma pigmentosum
Description

xeroderma pigmentosum

Data type

boolean

Alias
UMLS CUI [1]
C0043346
history of arsenic exposure
Description

arsenic exposure

Data type

boolean

Alias
UMLS CUI [1]
C0238690
known allergy to mal
Description

hypersensitivity methyl 5-aminolevulinate

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1134467
concomitant treatment with immunosuppressive medication
Description

concomitant treatment immunosuppressive medication

Data type

boolean

Alias
UMLS CUI [1,1]
C1707479
UMLS CUI [1,2]
C0021081
physical or mental conditions that most likely will prevent patients attending follow-up sessions
Description

Compliance behavior Limited Comorbidity

Data type

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488

Similar models

Eligibility Skin Neoplasms NCT01482104

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
gender; age
Item
male/female above 18 years of age
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Basal Cell Carcinoma
Item
1 or more primary histologically verified bcc, clinically assessed as of either superficial of nodular type
boolean
C0007117 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
breastfeeding
Item
breastfeeding
boolean
C0006147 (UMLS CUI [1])
gorlins syndrome
Item
gorlin's syndrome
boolean
C0004779 (UMLS CUI [1])
porphyria
Item
porphyria
boolean
C3463940 (UMLS CUI [1])
xeroderma pigmentosum
Item
xeroderma pigmentosum
boolean
C0043346 (UMLS CUI [1])
arsenic exposure
Item
history of arsenic exposure
boolean
C0238690 (UMLS CUI [1])
hypersensitivity methyl 5-aminolevulinate
Item
known allergy to mal
boolean
C0020517 (UMLS CUI [1,1])
C1134467 (UMLS CUI [1,2])
concomitant treatment immunosuppressive medication
Item
concomitant treatment with immunosuppressive medication
boolean
C1707479 (UMLS CUI [1,1])
C0021081 (UMLS CUI [1,2])
Compliance behavior Limited Comorbidity
Item
physical or mental conditions that most likely will prevent patients attending follow-up sessions
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])